Acute and Sustained Release of the Atrial Natriuretic Factor Prohormone N-Terminus with Acute Myocardial Infarction

This publication has 22 references indexed in Scilit:

• Increased Release of the N-Terminal and C-Terminal Portions of the Prohormone of Atrial Natriuretic Factor During Immersion-Induced Central Hypervolemia in Normal Humans
  Experimental Biology and Medicine, 1989
• Prohormone atrial natriuretic peptides 1-30 and 31-67 increase in hyperthyroidism and decrease in hypothyroidism
  The Lancet Healthy Longevity, 1989
• Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency.
  Heart, 1988
• Secretion of N-terminal fragment of gamma-human atrial natriuretic polypeptide.
  Hypertension, 1988
• Two new hormones: Prohormone atrial natriuretic peptides 1–30 and 31–67 circulate in man
  Biochemical and Biophysical Research Communications, 1988
• Circadian Rhythm of Prohormone Atrial Natriuretic Peptides 1-30, 31-67 and 99-126 in Man
  Chronobiology International, 1988
• Atrial natriuretic prohormone peptides 1–30, 31–67, and 79–98 vasodilate the aorta
  Biochemical and Biophysical Research Communications, 1987
• Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.
  Hypertension, 1984
• Bioactive Cardiac Substances: Potent Vasorelaxant Activity in Mammalian Atria
  Science, 1983
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
  Life Sciences, 1981